UK markets closed

Xeris Pharmaceuticals, Inc. (XERS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.7600-0.1200 (-6.38%)
At close: 04:00PM EDT
1.7700 +0.01 (+0.57%)
After hours: 07:36PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts6665
Avg. Estimate-0.11-0.09-0.39-0.22
Low estimate-0.14-0.15-0.53-0.4
High estimate-0.09-0.06-0.3-0.13
Year ago EPS-0.14-0.09-0.45-0.39
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts6666
Avg. Estimate44.6M47.92M183.73M218.17M
Low estimate41.8M44M176.8M196.5M
High estimate46.8M51.3M189.8M228.3M
Year ago sales38.01M48.32M163.91M183.73M
Sales growth (year/est)17.30%-0.80%12.10%18.70%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.13-0.12-0.1-0.12
Actual EPS-0.14-0.09-0.1-0.14
Difference-0.010.030-0.02
Surprise %-7.70%25.00%0.00%-16.70%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.11-0.09-0.39-0.22
7 days ago-0.1-0.09-0.38-0.22
30 days ago-0.1-0.09-0.38-0.22
60 days ago-0.1-0.08-0.34-0.11
90 days ago-0.07-0.06-0.27-0.05
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 days1111
Up last 30 days1111
Down last 7 daysN/AN/AN/AN/A
Down last 30 days1221
Growth estimatesXERSIndustrySector(s)S&P 500
Current qtr.21.40%N/AN/AN/A
Next qtr.N/AN/AN/AN/A
Current year13.30%N/AN/AN/A
Next year43.60%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A